Karachi: Pakistan’s pharmaceutical industry is experiencing significant growth, propelled by the support of the Special Investment Facilitation Council (SIFC). The industry reported record profits of 42.2 billion rupees last year, reflecting a seventy-eight percent increase.
According to Radio Pakistan, the sector’s robust performance followed deregulation, which led to improved pricing and reduced costs. This favorable environment allowed the industry to achieve unprecedented profits. Additionally, net sales in the pharmaceutical sector increased by fourteen percent, reaching 365.7 billion rupees last year, largely attributed to better pricing strategies.